Switch theme
Sign up to access all valuation multiples
Odontoprev SA is engaged in providing private dental care plans. The firm operates in three segments which include Corporate, Small And Medium-Sized Enterprises, Individual, and other.
1987
n/a
LTM Revenue $401M
LTM EBITDA $125M
$938M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Odontoprev has a last 12-month revenue of $401M and a last 12-month EBITDA of $125M.
In the most recent fiscal year, Odontoprev achieved revenue of $398M and an EBITDA of $188M.
Odontoprev expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Odontoprev valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $369M | $398M | XXX | XXX | XXX |
| Gross Profit | $196M | $114M | XXX | XXX | XXX |
| Gross Margin | 53% | 29% | XXX | XXX | XXX |
| EBITDA | $142M | $188M | XXX | XXX | XXX |
| EBITDA Margin | 39% | 47% | XXX | XXX | XXX |
| Net Profit | $78.8M | $89.1M | XXX | XXX | XXX |
| Net Margin | 21% | 22% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Odontoprev's stock price is BRL 11 (or $2).
Odontoprev has current market cap of BRL 5.7B (or $999M), and EV of BRL 5.4B (or $938M).
See Odontoprev trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $938M | $999M | XXX | XXX | XXX | XXX | $0.17 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Odontoprev has market cap of $999M and EV of $938M.
Odontoprev's trades at 2.3x LTM EV/Revenue multiple, and 7.5x LTM EBITDA.
Analysts estimate Odontoprev's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Odontoprev and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $938M | XXX | XXX | XXX |
| EV/Revenue | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 5.0x | XXX | XXX | XXX |
| P/E | 10.6x | XXX | XXX | XXX |
| P/E/Growth | 2.0x | XXX | XXX | XXX |
| EV/FCF | 10.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOdontoprev's NTM/LTM revenue growth is 6%
Odontoprev's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Odontoprev's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Odontoprev's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Odontoprev and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 47% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 53% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 5% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Odontoprev acquired XXX companies to date.
Last acquisition by Odontoprev was XXXXXXXX, XXXXX XXXXX XXXXXX . Odontoprev acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Odontoprev founded? | Odontoprev was founded in 1987. |
| Where is Odontoprev headquartered? | Odontoprev is headquartered in Brazil. |
| Is Odontoprev publicy listed? | Yes, Odontoprev is a public company listed on BVMF. |
| What is the stock symbol of Odontoprev? | Odontoprev trades under ODPV3 ticker. |
| When did Odontoprev go public? | Odontoprev went public in 2006. |
| Who are competitors of Odontoprev? | Similar companies to Odontoprev include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Odontoprev? | Odontoprev's current market cap is $999M |
| What is the current revenue of Odontoprev? | Odontoprev's last 12-month revenue is $401M. |
| What is the current EBITDA of Odontoprev? | Odontoprev's last 12-month EBITDA is $125M. |
| What is the current EV/Revenue multiple of Odontoprev? | Current revenue multiple of Odontoprev is 2.3x. |
| What is the current EV/EBITDA multiple of Odontoprev? | Current EBITDA multiple of Odontoprev is 7.5x. |
| What is the current revenue growth of Odontoprev? | Odontoprev revenue growth between 2023 and 2024 was 8%. |
| Is Odontoprev profitable? | Yes, Odontoprev is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
